Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Caillaud

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal De La Societe De Biologie|October 4, 2002
[Gaucher's and Fabry's diseases: biochemical and genetic aspects]Catherine Caillaud, Livia Poenaru
Handbook of Clinical Neurology|April 30, 2013
Neuronal ceroid lipofuscinosesBrigitte Chabrol, Catherine Caillaud, Berge Minassian
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Lentiviral vector delivery of shRNA into cultured primary myogenic cells: a tool for therapeutic target validationEmmanuel Richard, Gaelle Douillard-Guilloux, Catherine Caillaud
IUBMB Life|October 18, 2011
New insights into therapeutic options for Pompe diseaseEmmanuel Richard, Gaëlle Douillard-Guilloux, Catherine Caillaud
In Vitro Cellular & Developmental Biology. Animal|September 24, 2008
Correction of glycogenosis type 2 by muscle-specific lentiviral vectorEmmanuel Richard, Gaëlle Douillard-Guilloux, Lionel Batista, et al.
American Journal of Medical Genetics. Part A|February 3, 2004
Spondyloepimetaphyseal dysplasia of Maroteaux (pseudo-Morquio type II syndrome): report of a new patient and review of the literatureAndré Mégarbané, Pierre Maroteaux, Catherine Caillaud, et al.
The Journal of Gene Medicine|March 6, 2009
Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe diseaseGaëlle Douillard-Guilloux, Emmanuel Richard, Lionel Batista, et al.
Biochemical and Biophysical Research Communications|August 12, 2009
Immortalization of murine muscle cells from lysosomal alpha-glucosidase deficient mice: a new tool to study pathophysiology and assess therapeutic strategies for Pompe diseaseGaëlle Douillard-Guilloux, Vincent Mouly, Catherine Caillaud, et al.
European Journal of Clinical Pharmacology|January 29, 2008
Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women. In reference to pharmacovigilancePhilippe Mougenot, Olivier Lidove, Catherine Caillaud, et al.
American Journal of Medical Genetics. Part A|February 28, 2003
Leukodystrophy associated with oligodontia in a large inbred family: fortuitous association or new entity?Salim Atrouni, Antoine Darazé, Jean Tamraz, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal De La Societe De Biologie|October 4, 2002
[Gaucher's and Fabry's diseases: biochemical and genetic aspects]Catherine Caillaud, Livia Poenaru
Handbook of Clinical Neurology|April 30, 2013
Neuronal ceroid lipofuscinosesBrigitte Chabrol, Catherine Caillaud, Berge Minassian
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Lentiviral vector delivery of shRNA into cultured primary myogenic cells: a tool for therapeutic target validationEmmanuel Richard, Gaelle Douillard-Guilloux, Catherine Caillaud
IUBMB Life|October 18, 2011
New insights into therapeutic options for Pompe diseaseEmmanuel Richard, Gaëlle Douillard-Guilloux, Catherine Caillaud
In Vitro Cellular & Developmental Biology. Animal|September 24, 2008
Correction of glycogenosis type 2 by muscle-specific lentiviral vectorEmmanuel Richard, Gaëlle Douillard-Guilloux, Lionel Batista, et al.
American Journal of Medical Genetics. Part A|February 3, 2004
Spondyloepimetaphyseal dysplasia of Maroteaux (pseudo-Morquio type II syndrome): report of a new patient and review of the literatureAndré Mégarbané, Pierre Maroteaux, Catherine Caillaud, et al.
The Journal of Gene Medicine|March 6, 2009
Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe diseaseGaëlle Douillard-Guilloux, Emmanuel Richard, Lionel Batista, et al.
Biochemical and Biophysical Research Communications|August 12, 2009
Immortalization of murine muscle cells from lysosomal alpha-glucosidase deficient mice: a new tool to study pathophysiology and assess therapeutic strategies for Pompe diseaseGaëlle Douillard-Guilloux, Vincent Mouly, Catherine Caillaud, et al.
European Journal of Clinical Pharmacology|January 29, 2008
Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women. In reference to pharmacovigilancePhilippe Mougenot, Olivier Lidove, Catherine Caillaud, et al.
American Journal of Medical Genetics. Part A|February 28, 2003
Leukodystrophy associated with oligodontia in a large inbred family: fortuitous association or new entity?Salim Atrouni, Antoine Darazé, Jean Tamraz, et al.
Pageof 9